Darkening and eruptive nevi during treatment with erlotinib

Cutis. 2019 Jul;104(1):E19-E21.

Authors

Stephen Hemperly¹, Tanya Ermolovich², Nektarios I Lountzis², Hina A Sheikh³, Stephen M Purcell²

Affiliations

¹ Dermatology Residency Program, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.
² Advanced Dermatology Associates, LTD, Allentown, Pennsylvania, USA.
³ Department of Dermatopathology, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.

PMID: 31487352

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Erlotinib Hydrochloride / adverse effects*
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Male
Melanoma / chemically induced*
Melanoma / pathology
Nevus, Pigmented / chemically induced*
Nevus, Pigmented / pathology
Protein Kinase Inhibitors / adverse effects*
Skin Neoplasms / chemically induced*
Skin Neoplasms / pathology

Substances

Protein Kinase Inhibitors
Erlotinib Hydrochloride